Ranbaxy Laboratories is in speaks with Ind-Swift Labs

Indian medicine manufacturer Ranbaxy Laboratories is in speaks with Ind-Swift Labs to source ingredient to produce a generic version of Pfizer Inc.’s (PFE) Lipitor blood cholesterol medicine.

Ind-Swift vice chairman N. R. Munjal stated that the firm is talking about various choices to deliver intermediate or final active pharmaceutical raw materials atorvastatin to Ranbaxy.

Ranbaxy plans to release the cholesterol medicine in the United states. at the end of November, but regulatory and producing issues at the Indian firm have late FDA authorization for the medicine.

Be Sociable, Share!
Tags: ,

Stock Market Basics For Beginners

What is a Demat Account ?

What is a Demat Account ? Demat account permit you to buy, sell and transact shares without the endless paperwork and delays. It is also secure , safe, and convenient. The term ...…

Initial Public Offer

Initial Public Offer Initial Public Offer. The initial sale of share by a firm for the public. The commonest reason for a firm to start an IPO is ...…

Assets

Assets Assets is owned by a company or a person. Property are listed on a company's balance sheet and include tangible things like inventory, equipment, and ...…

Which Site Give Guide About Penny Stock?

Which Site Give Guide About Penny Stock? We have included the part on Penny Stocks to create novice traders wise to these types of scams. We have viewed a lot of web ...…

Company Fixed Deposits

Company Fixed Deposits Company Fixed Deposits are shortterm (6 months) to mediumterm (3 to 5 yrs) borrowing by firms at a fixed interest rate that is payable monthly, ...…

Indian Share Tips

NSE Investment Site

Market Update

Share Guide

Designed by VMV
web
analytics